Publication | Closed Access

Effects of third generation aromatase inhibitors on bone health and other safety parameters: Results of an open, randomised, multi-centre study of letrozole, exemestane and anastrozole in healthy postmenopausal women

Bone DiseaseMulti-centre StudyBone HealthMedicineOther Safety ParametersAromatasePharmacotherapyOsteoporosisMenopauseHealthy Postmenopausal WomenPharmacologyOrthopaedic SurgeryBone MetabolismWomen's HealthMenopause Hormone Therapy